Case series of patients with chronic foot ulcers treated with autologous platelet-rich plasma

Journal of Dermatology

Volumn 42, Issue 3, 2015, Pages 288-295

  Yotsu, Rie R ^a,b   Hagiwara, Shotaro ^a   Okochi, Hitoshi ^a   Tamaki, Takeshi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b National Suruga Sanatorium   (Japan)

Author keywords

chronic wound; cutaneous polyarteritis nodosa; diabetic foot ulcer; peripheral arterial disease; platelet rich plasma; wound healing

Indexed keywords

BROMELAIN; CEFAZOLIN; CEFTRIAXONE; PETROLATUM; PREDNISOLONE; SULFADIAZINE SILVER;

ADULT; AGED; AMPUTATION; ANTIBIOTIC THERAPY; ARTICLE; AUTOTRANSPLANTATION; CASE STUDY; CELLULITIS; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DEBRIDEMENT; DIABETES MELLITUS; DISEASE COURSE; DISTAL PHALANX; DRUG DOSE INCREASE; EPITHELIZATION; FOOT ULCER; GANGRENE; GRANULATION TISSUE; HALLUX; HUMAN; LOCAL THERAPY; MALE; MICROCIRCULATION; MIDDLE AGED; OSTEOMYELITIS; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLANTAR ULCER; POLYARTERITIS NODOSA; THROMBOCYTE RICH PLASMA; TISSUE NECROSIS; TRANSPARENT DRESSING; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION; CASE REPORT; CHRONIC DISEASE; COMPLICATION; CROHN DISEASE; DIABETIC FOOT;

AGED; CHRONIC DISEASE; CROHN DISEASE; DIABETIC FOOT; FOOT ULCER; HUMANS; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; POLYARTERITIS NODOSA;

EID: 84924096311     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12777     Document Type: Article

References (45)

1. Driver VR, Fabbi M, Lavery LA, Gibbons G,. The costs of diabetic foot: the economic case for the limb salvage team. J Am Podiatr Med Assoc 2010; 100: 335-341.
2. Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR,. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev 2012; 28 (Suppl 1): 107-111.
3. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J,. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724.
4. American Diabetes Association. Economic costs of diabetes in the US In 2007. Diabetes Care 2008; 31: 596-615.
5. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL,. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986; 204: 322-330
6. Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW,. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992; 15: 1598-1604.
7. Hamada T, Sonoda M, Hayashi Y, et al,. Investigations into centrifugal separations for preparation of platelet rich plasma (PRP). Ohu Univ Dent J 2004; 31: 243-247.
8. Rappl LM,. Effect of platelet rich plasma gel in a physiologically relevant platelet concentration on wounds in persons with spinal cord injury. Int Wound J 2011; 8: 187-195.
9. Cooper DM, Yu EZ, Hennessey P, Ko F, Robson MC,. Determination of endogenous cytokines in chronic wounds. Ann Surg 1994; 219: 688-691; discussion 91-2.
10. Baltzis D, Eleftheriadou I, Veves A,. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther 2014; 31: 817-836.
11. Mehta S, Watson JT,. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma 2008; 22: 432-438.
12. Singer AJ, Clark RA,. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
13. Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, Cerra F,. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990; 170: 56-60.
14. Ganio C, Tenewitz FE, Wilson RC, Moyles BG,. The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors. J Foot Ankle Surg 1993; 32: 263-268.
15. Spencer EM, Tokunaga A, Hunt TK,. Insulin-like growth factor binding protein-3 is present in the alpha-granules of platelets. Endocrinology 1993; 132: 996-1001.
16. Slater M, Patava J, Kingham K, Mason RS,. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995; 13: 655-663.
17. Su CY, Kuo YP, Nieh HL, Tseng YH, Burnouf T,. Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 2008; 48: 2414-2420.
18. Eppley BL, Woodell JE, Higgins J,. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 2004; 114: 1502-1508.
19. Hosgood G,. Wound healing. The role of platelet-derived growth factor and transforming growth factor beta. Vet Surg 1993; 22: 490-495.
20. Kim DH, Kim JY, Seo SH, Ahn HH, Kye YC, Choi JE,. Recalcitrant cutaneous ulcer of comorbid patient treated with platelet rich plasma: a case report. J Korean Med Sci 2012; 27: 1604-1606.
21. Munirah S, Samsudin OC, Chen HC, Salmah SH, Aminuddin BS, Ruszymah BH,. Articular cartilage restoration in load-bearing osteochondral defects by implantation of autologous chondrocyte-fibrin constructs: an experimental study in sheep. J Bone Joint Surg 2007; 89: 1099-1109.
22. Tang YQ, Yeaman MR, Selsted ME,. Antimicrobial peptides from human platelets. Infect Immun 2002; 70: 6524-6533.
23. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T,. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Joint Surg 2007; 89: 417-420.
24. Yotsu RR, Pham NM, Oe M, et al,. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type. J Diabetes Complications 2014; 28: 528-535.
25. Driver VR, Hanft J, Fylling CP, Beriou JM,. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006; 52: 68-70, 2, 4 passim.
26. Dumville JC, Hinchliffe RJ, Cullum N, et al,. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev 2013; 10: CD010318.
27. Huang C, Leavitt T, Bayer LR, Orgill DP,. Effect of negative pressure wound therapy on wound healing. Curr Probl Surg 2014; 51: 301-331.
28. Park KY, Kim IS, Yeo IK, Kim BJ, Kim MN,. Treatment of refractory venous stasis ulcers with autologous platelet-rich plasma and light-emitting diodes: a pilot study. J Dermatolog Treat 2013; 24: 332-335.
29. Nikolidakis D, Jansen JA,. The biology of platelet-rich plasma and its application in oral surgery: literature review. Tissue Eng Part B Rev 2008; 14: 249-258.
30. Shashikiran ND, Reddy VV, Yavagal CM, Zakirulla M,. Applications of platelet-rich plasma (PRP) in contemporary pediatric dentistry. J Clin Pediatr Dent 2006; 30: 283-286.
31. Pietramaggiori G, Kaipainen A, Czeczuga JM, Wagner CT, Orgill DP,. Freeze-dried platelet-rich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regen 2006; 14: 573-580.
32. Lacci KM, Dardik A,. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med 2010; 83: 1-9.
33. Edmonds M, Bates M, Doxford M, Gough A, Foster A,. New treatments in ulcer healing and wound infection. Diabetes Metab Res Rev 2000; 16 (Suppl 1): S51-S54.
34. Mehrannia M, Vaezi M, Yousefshahi F, Rouhipour N,. Platelet rich plasma for treatment of nonhealing diabetic foot ulcers: a case report. Can J Diabetes 2014; 38: 5-8.
35. Davis VL, Abukabda AB, Radio NM, et al,. Platelet-rich preparations to improve healing. Part I: workable options for every size practice. J Oral Implantol 2014; 40: 500-510.
36. Knighton DR, Doucette M, Fiegel VD, Ciresi K, Butler E, Austin L,. The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res 1988; 266: 319-329.
37. Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH,. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg 1991; 14: 526-532.
38. Stacey MC, Mata SD, Trengove NJ, Mather CA,. Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 2000; 20: 296-301.
39. Senet P, Bon FX, Benbunan M, Bussel A, Traineau R, Calvo F,. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 2003; 38: 1342-1348.
40. Weed B, Davis MDP, Felty CL, et al,. Autologous platelet lysate product versus placebo in patients with chronic leg ulcerations: a pilot study using a randomized, double-blind, placebo-controlled trial. Wounds 2004; 16: 273-282.
41. Kakagia D, Kazakos K, Xarchas K, et al,. Synergistic action of protease-modulating matrix and autologous growth factors in healing diabetic foot ulcers. A prospective randomized trial. J Diabetes Complications 2007; 21: 387-391.
42. Anitua E, Aguirre JJ, Algorta J, et al,. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 2008; 84: 415-421.
43. Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, et al,. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev 2012; 10: CD006899.
44. Greppi N, Mazzucco L, Galetti G, et al,. Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients. Biologicals 2011; 39: 73-80.
45. Sano H, Ichioka S, Minamimura A, Tanaka R, Ikebuchi K, Suzuki M,. Treatment of chronic ulcer with elastic plasma protein and platelet film for wound dressing. J Plast Surg Hand Surg 2013; 47: 462-466.